Delivery Order SPE2DB22D9207-SPE2DB25FH5DR
- Not listed
- The Defense Logistics Agency awarded a $10,415.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems on September 9, 2025, with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor on this award. This delivery order is issued...
- The Defense Logistics Agency awarded a $10,415.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems on August 29, 2025, with an ultimate completion date of September 22, 2025. This delivery order was issued without a set-aside designation and represents a specific pharmaceutical product fulfillment under the agency's broader pharmaceutical supply operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler...
- The Defense Logistics Agency awarded a $12,498.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order represents a small purchase of contraceptive medical devices issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The award was made without set-aside designation, allowing the woman-owned small business based in...
- The Defense Logistics Agency awarded a $16,612.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a specific product requisition under DMS's larger indefinite delivery contract with DLA, which is valued at...
- The Defense Logistics Agency awarded a $7,811.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of June 24, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its location in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small...
- The Defense Logistics Agency awarded a $20,830.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of July 17, 2025. This delivery order was issued without a set-aside designation and represents a purchase of contraceptive devices to support military health facility needs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor,...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $41,661.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation to supply this contraceptive implant device. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $15,623.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 2, 2025. This award was issued without a set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA, valued at approximately $500 million and...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5DRDelivery Order
The Defense Logistics Agency awarded a $14,008.45 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on August 19, 2025, with an ultimate completion date of September 10, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. No set-aside designation was applied to this award, allowing the company to compete directly in the open federal procurement market. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The IDC, operating under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. Mirena systems, a contraceptive implant device, fall within the company's established portfolio of pharmaceutical and medical products that support military health system requirements. This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 8/19/25 |